In summary, this study reveals that inhibiting CDC20 activity genetically or pharmacologically restrains DNA damage repair and enhances radiation-induced intrinsic apoptosis of CRC in vitro and in vivo. This evidence concerns the gene CDC20 and colorectal carcinoma.